The milk rejection sign: a natural tumor marker
Saber, A.; Dardik, H.; Ibrahim, I.M.; Wolodiger, F.
American Surgeon 62(12): 998-999
1996
ISSN/ISBN: 0003-1348 PMID: 8955234 Document Number: 466783
Early discovery of breast cancer in the lactating female will result in improved survival rates. One such marker is the "milk rejection sign," which has rarely been described and consists of the rejection by the nursing infant of the lactating breast that harbors an occult breast carcinoma. Recognition of this particular sign is vital and will enable early diagnosis and improved prognosis.
Document emailed within 1 workday
Related Documents
Carrillo-Esper, R.úl.; Carrillo-Córdova, J.R.úl.; Carrillo-Córdova, L.D. 2010: Cleft lobe sign. a curious clinical sign or an ischemic heart disease marker? Gaceta Medica de Mexico 146(3): 225-227Waghmare, P.; Goswami, K. 2016: Microalbuminuria: a Mere Marker or An Ominous Sign? Journal of the Association of Physicians of India 64(3): 61-65
Boveda, S.; Galinier, M.; Lagrange, P.; Lagrange, A.; Cérène, A.; Delay, M.; Baccar, H.; Defaye, P.; Bounhoure, J.P.; Fauvel, J.M. 2001: Atrial flutter: a possible early sign of acute rejection in heart transplantation. A case report Archives des Maladies du Coeur et des Vaisseaux 94(6): 613-616
Cosson, C.; Myara, I.; Guillemain, R.; Amrein, C.; Dreyfus, G.; Moatti, N. 1989: Serum prolactin as a rejection marker in heart transplantation Clinical Chemistry 35(3): 492-493
Itolikar, S.M.; Salagre, S.B.; Kalal, C.R. 2012: 'Hummingbird sign', 'penguin sign' and 'Mickey mouse sign' in progressive supranuclear palsy Journal of the Association of Physicians of India 60: 52
Marks, W.H.; Borgstrom, A.; Sollinger, H.; Marks, C.; Lorber, M.I. 1990: Serum anodal trypsinogen is a predictive biochemical marker for pancreas allograft rejection Transplantation Proceedings 22(2): 673-674
Hiramoto, R.N.; Ghanta, V.K.; Soong, S.J.; Hurst, D.C. 1977: An experimental approach to relate a tumor-associated enzyme marker to tumor cell numbers Cancer Research 37(2): 365-368
Oremek, G.M.; Teigelkamp, S.; Kramer, W.; Eigenbrodt, E.; Usadel, K.H. 1999: The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma Anticancer Research 19(4a): 2599-2601
Kos, T.; Aksoy, S.; Sendur, M.A.N.; Arik, Z.; Civelek, B.; Kandemir, N.; Ozdemir, N.Y.; Zengin, N.; Altundag, K. 2013: Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes Journal of BUON: Official Journal of the Balkan Union of Oncology 18(3): 608-613
Hardt, P.D.; Ngoumou, B.K.; Rupp, J.; Schnell-Kretschmer, H.; Kloer, H.U. 2000: Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer Anticancer Research 20(6d): 4965-4968
Oremek, G.M.; Rutner, F.; Sapoutzis, N.; Sauer-Eppel, H. 2003: Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy Anticancer Research 23(2a): 1155-1158
Chiewvit, S.; Phasuk, S.; Surapako, S.; Juiklom, W.; Chiewvit, P. 2010: Screening may not be accurate word to represent the cases submitted to PET/CT evaluation for primary tumor in a patient who has abnormal serum tumor marker Journal of the Medical Association of Thailand 93(3): 330-336
McKee, J.S.; Durocher, J.J.; Bose, R.; Gusdal, M.I.; Sharma, G.P.; Pinsky, C.; Gallop, D. 1985: Dynamic studies of positron-emitting putative tumor marker 132Cs in mice show differential tumor and regional uptake Cancer Detection and Prevention 8(1-2): 87-93
Webster, G.A.; Bowles, M.J.; Karim, M.S.; Wood, R.F.; Pockley, A.G. 1994: Activation antigen expression on peripheral blood neutrophils: a novel marker of rejection following rat small bowel transplantation Transplantation Proceedings 26(3): 1522
Mohanakumar, T.; Hoshinaga, K.; Wood, N.L.; Szentpetery, S.; Lower, R.R. 1986: Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients Transplantation 42(6): 691-694
Abramson, L.P.; Pahl, E.; Huang, L.; Stellmach, V.; Rodgers, S.; Mavroudis, C.; Backer, C.L.; Arensman, R.M.; Crawford, S.E. 2002: Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation Transplantation 73(1): 153-156
Schroeder, C.; Horner, S.; Bürger, N.; Engemann, C.; Bange, U.; Knoop, E.V.; Gabert, Jörg. 2012: Improving the sensitivity of the IBR-gE ELISA for testing IBR marker vaccinated cows from bulk milk Berliner und Munchener Tierarztliche Wochenschrift 125(7-8): 290-296
Liu, X.; Zhang, L.; Zhang, M.; Ma, Y.; Xu, X.; Cai, Y. 2000: Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect Chinese Medical Journal 113(2): 167-171
Nagai, A.; Zbar, B.; Terata, N.; Hovis, J. 1983: Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells Cancer Research 43(12 Part 1): 5783-5788
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793